Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Städler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biostatistics (Oxford, England)|June 30, 2014
Multivariate gene-set testing based on graphical modelsNicolas Städler, Sach Mukherjee
Frontiers in Immunology|September 5, 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapiesDavid Dejardin, Anton Kraxner, Emilie Schindler, et al.
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Statistics in Medicine|January 29, 2020
Bayesian hierarchical meta-analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate dataTasos Papanikos, John R Thompson, Keith R Abrams, et al.
Bioinformatics (Oxford, England)|May 24, 2017
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case studyNicolas Städler, Frank Dondelinger, Steven M Hill, et al.
Statistics in Medicine|May 28, 2019
Bivariate network meta-analysis for surrogate endpoint evaluationSylwia Bujkiewicz, Dan Jackson, John R Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
A Composite Decision Rule of CD8+ T-cell Density in Tumor Biopsies Predicts Efficacy in Early-stage, Immunotherapy TrialsDavid Dejardin, Anton Kraxner, Annika Blank, et al.
Cancer Research Communications|February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsValentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Nature Communications|January 29, 2015
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biostatistics (Oxford, England)|June 30, 2014
Multivariate gene-set testing based on graphical modelsNicolas Städler, Sach Mukherjee
Frontiers in Immunology|September 5, 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapiesDavid Dejardin, Anton Kraxner, Emilie Schindler, et al.
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Statistics in Medicine|January 29, 2020
Bayesian hierarchical meta-analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate dataTasos Papanikos, John R Thompson, Keith R Abrams, et al.
Bioinformatics (Oxford, England)|May 24, 2017
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case studyNicolas Städler, Frank Dondelinger, Steven M Hill, et al.
Statistics in Medicine|May 28, 2019
Bivariate network meta-analysis for surrogate endpoint evaluationSylwia Bujkiewicz, Dan Jackson, John R Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
A Composite Decision Rule of CD8+ T-cell Density in Tumor Biopsies Predicts Efficacy in Early-stage, Immunotherapy TrialsDavid Dejardin, Anton Kraxner, Annika Blank, et al.
Cancer Research Communications|February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsValentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Nature Communications|January 29, 2015
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Pageof 1